Understanding how a specific enzyme affects blood vessel development and disorders.
Sphingosine kinase 1 plays a key role in defective elastin-induced arterial hypermuscularization
This study is looking at how a specific protein affects heart problems in kids caused by issues with a gene that helps make elastin, which is important for healthy blood vessels, and it hopes to find new ways to help improve blood flow and prevent serious heart conditions.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11055294 on NIH RePORTER |
What this research studies
This research investigates the role of sphingosine kinase 1 in the development of arterial conditions related to elastin deficiencies, particularly in children. It focuses on how mutations in the elastin gene can lead to serious heart issues, such as supravalvular aortic stenosis and patent ductus arteriosus. By studying the mechanisms behind smooth muscle cell accumulation in these conditions, the research aims to identify potential therapeutic strategies to manage or prevent these heart defects. Patients may benefit from insights into how to improve blood flow and reduce complications associated with these vascular disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old who have been diagnosed with conditions like supravalvular aortic stenosis or patent ductus arteriosus.
Not a fit: Patients with heart conditions unrelated to elastin deficiencies or those over 11 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for children with heart defects related to elastin deficiencies.
How similar studies have performed: Previous research has shown promising results in understanding the role of similar biological pathways in vascular development, suggesting that this approach may yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Saito, Junichi — Yale University
- Study coordinator: Saito, Junichi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.